Despite the major success in the treatment of chronic renal failure, many unsolved problems remain, Among these, is the symptom of skeletal muscle weakness, It can be seen from the review of the work undertaken to evaluate weakness in uraemic patients that there have been few objective physiological studies of the mechanisms that may contribute to this symptom, Weakness, a failure to generate force (1) , is the measure of progress in muscle disease and as such could represent disturbances of structure or function, Its possible causes have been considered in three broad categories (2) , namely defective electromechanical activation (impaired neuromuscular transmission or impaired excitation-contraction coupling), impaired short-term energy supply, or inadequate contractile machinery. Impaired neuromuscular transmission as a cause of weakness is not seen in normal muscle but occurs in myasthenia gravis, It has not been reported in uraemic patients, and a myasthenia gravis pattern of weakness is not seen.
Impaired excitation-contracting coupling has been suggested by Brautbar (3) on the basis of the work of Heimberg et al (4) , who found markedly reduced calcium ion transport by the sarcoplasmic reticulum. As calcium release from the sarcoplasmic reticulum is of critical importance in the sequence leading from excitation to contraction, these findings led Brautbar to conclude, from biochemistry and not physiological measurements, that dialysis patients have excitation-contraction coupling abnormalities. Evidence for this defect was sought in a recent objective physiological study (5) by comparing the forces of contraction resulting from stimulation at low frequencies (20 Hz) with those obtained at higher frequencies (50 Hz) by transcutaneous stimulation of the quadriceps. This study found no indication of the selective low frequency force loss associated with impairment of excitation-contraction coupling.
Impaired short-term energy supply is a major determinant of muscle function. The immediate source of energy for muscular contraction and relaxation is ATP. The supply of ATP in muscle is maintained (in the short-term) by the breakdown of phosphocreatine. Reports of ATP production in uraemia have not been consistent. Some have reported impaired oxidative energy metabolism (6) , and others found enhanced production of ATP (7) . Although the corre-lation of these abnormalities to muscle strenght remains unclear, it is likely that weakness in dialysis patients is associated with impaired oxidative energy metabolism and this warrants further investigation.
Inadequate contractile machinery (smaller or fewer muscle cells). The force produced depends on the cross sectional area of the muscle and thus any degree of muscle wasting would lead to loss of force. Contributing to muscle wasting in uraemic patients is the aging of the dialysis population, as increasing muscle weakness is a feature of old age and is associated with a shrinking total muscle mass (8) . In recent work we demonstrated a significant negative correlation between muscle force and age (5) .
However, muscle wasting is not always confirmed by imaging of skeletal muscle (ultrasound/MRI), which can give an accurate measurement of the cross-section of the muscle and an indication of the composition of the muscle (i.e. whether it has been replaced with fat or fibrous tissue).
In addition, lack of central drive or motivation must also be considered in view of the psychosocial factors common in dialysis patients. This may lead to a failure to initiate force production or to sustain motor unit recruitment so that force is lost prematurely. Lack of motivation could be due to a coexisting physical illnesses or to psychological factors such as stress, sleep disturbances, and depression (9) .
Other factors contribute to the weakness and merit discussion. Muscle histology, nutrition and dialysis adequacy: Despite clinical and light microscopic reports on pathological changes in the muscles of uraemic patients (10, 11) , the question of whether there is a significant uraemic myopathy has not been resolved. Few studies have indicated objective changes in the contraction-relaxation characteristics of the adductor pollicis in malnourished uraemic (12) and non-uraemic patients (13) . Inadequate nutrition in many patients is due to under-dialysis, and support or malnutrition as an aetiological factor in muscle weakness is provided in a recent study (14) by the absence of any biopsy evidence of destruction of muscle cells. In this study, a tendency to a smaller fibre area in the quadriceps muscle was demonstrated. This was more pronounced in the malnourished group, where the significantly reduced type liB mean fibre area correlated with strength. Type II fibres in the quadriceps are stronger and relax faster than type I and thus their reduction is likely to contribute to weakness.
Hormonal abnormalities: A role for vitamin D deficiency has been suggested because skeletal myopathy is a common finding in patients with vitamin D deficiency. Rodman and Baker (15) , examined the kinetics of muscle contraction in vitamin D deficient rats and found prolonged relaxation phases of muscle contraction independent of serum calcium, phosphorus or parathyroid levels. Osteomalacia, once common in uraemic patients, far less frequent since the use of calcitriol, but may still be seen with aluminium toxicity. Primary and secondary hyperparathyroidism may present with proximal muscle weakness (16) , and several studies demonstrated impaired energy metabolism in states of excess PTH (17) . Oestrogen levels are related to changes in strength in women, as shown by studies investigating force production during the menstrual cycle, where strenght was found to be greater around ovulation, when oestrogen levels are at their height (18) . Phillips et al (19) , in another study, found that muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. These findings have important implications in the weakness of female dialysis patients, who are oligomenorrhoeic and oestrogen deficient at an early age.
Electrolyte abnormalities: Electrolytes, essential to normal skeletal muscle contraction are thought to play a role in muscle weakness. Excess accumulation of ammonia and hydrogen ions after strenuous bouts of physical activity (20) may slow muscle contractions and decrease muscle tension development. Renal failure causes abnormal levels of electrolytes such as calcium, magnesium, potassium, or sodium which may cause muscle weakness.
Carnitine depletion and impaired energy intake abnormalities: Carnitine deficiency leads to severe myopathy and its deficiency in dialysis patients has been claimed to be responsible for the observed myopathy. It seems likely that carnitine deficiency plays no significant role in muscle strength and endurance in uraemic patients, as the efficacy of L-carnitine supplementation on exercise performance has been variable (21, 22) .
Physical activity, depression and mitochondrial enzymes: Structural damage of the mitochondria and decreased skeletal muscle blood supply are reported as possible causes of defective mitochondrial function or structure leading to reduced energy production. Reduced habitual activity (23) and depression in dialysis patients (9) may also reduce muscle protein synthesis and decrease 186 mitochondrial enzyme activity (24) . Low protein synthetic rates could lead to a decrease in muscle mass, since 90% of muscle dry weight consists of protein. Low mitochondrial enzymes activities would decrease exercise endurance and cause fatigue. In a recent study (14) , the mitochondrial enzymes were reduced in the dialysis patients, but the cause of this is not clear. Ultrastructural analysis of the muscle biopsies revealed no major structural abnormalities of the mitochondria, thus ruling out structural damage as a cause, but an increase in glycogen content, possibly owing to a reduced physical activity, could account for reduced mitochondrial enzymes. The finding of severe restriction to activity and depression in most of the dialysis patients studied support this explanation. The activity of each enzyme correlated linearly with the Karnofsky Performance Status Scale and inversely with the depression sub-scale of the Hospital Anxiety and Depression Scale.
Uraemic myopathy does exist but is under-investigated. It cannot be explained by defective electromechanical activation and at most there is minimal evidence of myopathic changes in the uraemic muscle. The frequently reported type II fibre atrophy is a non-specific finding, also seen in several other conditions such as malnutrition and disuse. Current evidence suggests that malnutrition, impaired energy production and transport, and physical inactivity (leading to muscle wasting/reduced cross sectional area and reduced mitochondrial enzymes), are the most important causes of observed muscle abnormalities. They are aggravated by the concomitant psychological factors such as depression and sleep disturbances.
Muscle weakness is an important factor that limits the full and successful rehabilitation of dialysis patients. A better understanding of its pathophysiology should contribute to better management and improve both physical and mental well being. 
